Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 25

CN50 - Patient-reported outcome measures and supportive care need assessment in patients in a slovenian tertiary oncology centre

Date

21 Oct 2023

Session

Poster session 25

Topics

Supportive Care and Symptom Management

Tumour Site

Presenters

Majda Causevic

Citation

Annals of Oncology (2023) 34 (suppl_2): S1229-S1256. 10.1016/annonc/annonc1321

Authors

M. Causevic1, A. Grbic2

Author affiliations

  • 1 Supportive Care Department, Institute of Oncology Ljubljana, 1360 - Vrhnika/SI
  • 2 Head Nurse, Institute of Oncology Ljubljana, 1000 - Ljubljana/SI

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract CN50

Background

Patient-reported outcome measures (PROMs) are tools usually questionnaires, to assess elements of their experience such as symptom burden, functional status and psychological and emotional well-being from patient 's perspective on how illness or care impacts on their well being. The aim of our study is to analyse the psychophysical social well-being and quality of life of cancer patients prior to treatment, the approach of the multidisciplinary team to identify and manage patient needs, and the barriers and facilitators to the use of PROMs in a Slovenian tertiary oncology centre, in order to inform the wider uptake of PROMs.

Methods

From December 2022 to August 2023, PROMs data collected for patients accessing care at a tertiary cancer centre will be retrospectively analysed. Data will be collected using the standardised EORTC C30 questionnaire.

Results

The results will be used to identify, according to each of the domains, the physical, emotional, cognitive, social functioning and functioning, symptom burden, health status and quality of life of the patients before the start of treatment and the use of a multidisciplinary approach to meet the patient's needs. Perceived risks, barriers and facilitators to the use of PROMS will be presented.

Conclusions

This study will demonstrate the benefits of using systematic PROMs monitoring and follow-up to screen patients' needs and provide holistic approach for cancer patients. It will also highlight opportunities, barriers and facilitators to PROMS implementation occur.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Institute of Oncology Ljubljana.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.